Open AccessCHRONIC HEPATITIS B VIRUS INFECTION
Author(s) -
Ejaz Ahmed
Publication year - 2006
Publication title -
the professional medical journal/the professional medical journal
Language(s) - English
Resource type - Journals
eISSN - 2071-7733
pISSN - 1024-8919
DOI - 10.29309/tpmj/2006.13.04.4958
Subject(s) - medicine , entecavir , lamivudine , telbivudine , chronic hepatitis , virology , hepatitis b , hepatitis b virus , virus
Hepatitis B virus is a major health dilemma causing an enormous burden on the health care systemand a major source of patient’s suffering. Over the last decade, far-reaching research has not only led to theenhancement of present management of chronic hepatitis B, but has also revealed new options for the treatment ofthis appalling disease. Presently interferon alpha- 2b, lamivudine, adenofovir dipivoxil and tenofovir are being employedfor the management of chronic hepatitis B infection. However, extensive research is being carried out to assess theefficacy of peg- interferon, emtricitabine, entecavir and telbivudine in treating chronic hepatitis B infection.